Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Spyros Papamichos"'
Autor:
Anna Christoforidou, Georgios Kapsas, Zoe Bezirgiannidou, Spyros Papamichos, Ioannis Kotsianidis
Publikováno v:
Turkish Journal of Hematology, Vol 35, Iss 2, Pp 147-149 (2018)
Externí odkaz:
https://doaj.org/article/e7399090818d4fdf95562afc4841b360
Autor:
Michael Doulberis, Apostolis Papaefthymiou, Georgios Kotronis, Dimitra Gialamprinou, Elpidoforos S. Soteriades, Anthony Kyriakopoulos, Eleftherios Chatzimichael, Kyriaki Kafafyllidou, Christos Liatsos, Ioannis Chatzistefanou, Paul Anagnostis, Vitalii Semenin, Smaragda Ntona, Ioanna Gkolia, Dimitrios David Papazoglou, Nikolaos Tsinonis, Spyros Papamichos, Hristos Kirbas, Petros Zikos, Dionisios Niafas, Jannis Kountouras
Publikováno v:
Medicina, Vol 57, Iss 3, p 253 (2021)
The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic warrants an imperative necessity for effective and safe vaccination, to restrain Coronavirus disease 2019 (COVID-19) including transmissibility, morbidity, and mortalit
Externí odkaz:
https://doaj.org/article/75a498b32223415d8c651bee73d47db3
Autor:
Eleftheria Lamprianidou, Chryssoula Kordella, Menelaos Papoutselis, Zoi Bezyrgiannidou, Evangelia Nakou, Spyros Papamichos, Emmanouil Spanoudakis, Andreas Giannopoulos, Katerina Zoi, Ioannis Kotsianidis
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 9, Iss 1, Pp e2017066-e2017066 (2017)
It has been suggested that myeloid neoplasms with isolated isochromosome 17q[MN i(17q)] comprise a distinct entity with poor prognosis. However, literature reports show a considerable clinical and molecular heterogeneity. We describe a 58-year-old ma
Externí odkaz:
https://doaj.org/article/7639c8858b6d4caea051a90f42bc17a6
Autor:
Zoe Bezirgiannidou, Anna Christoforidou, Eftychia Kontekaki, Athanasios Anastasiadis, Spyros Papamichos, Helen Menexidou, Dimitrios Margaritis, George Martinis, Elpidoforos Mandadakis
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 8, Iss 0, Pp e201653-e201653 (2016)
Abstract Background: Hyperhemolytic Syndrome or Hyperhemolytic Transfusion Reaction (HHTR), a life-threatening subset of Delayed Hemolytic Transfusion Reaction (DHTR) is characterized by destruction of both transfused and autologous erythrocytes evid
Externí odkaz:
https://doaj.org/article/75a07f61df9f41168ab44ef83d821ab6
Autor:
Anna Christoforidou, Eftychia Kontekaki, Athanasios Anastasiadis, Spyros Papamichos, Helen Menexidou, Dimitrios Margaritis, George Martinis, Elpidoforos Mandadakis
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases. 8:201653
Background: Hyperhemolytic Syndrome or Hyperhemolytic Transfusion Reaction (HHTR), a life-threatening subset of Delayed Hemolytic Transfusion Reaction (DHTR) is characterized by destruction of both transfused and autologous erythrocytes evidenced by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52f74a3dfb1b407dcd4a33589ce14aa1
https://doi.org/10.4084/mjhid.2016.53
https://doi.org/10.4084/mjhid.2016.53